Last 369.75 GBp
Change Today +0.50 / 0.14%
Volume 113.7K
CLIN On Other Exchanges
Symbol
Exchange
London
OTC US
Stuttgart
As of 11:35 AM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ian James Nicholson B.Sc., MBA

Chief Executive Officer and Executive Director, F2G Ltd
AgeTotal Calculated CompensationThis person is connected to 24 board members in 4 different organizations across 8 different industries.

See Board Relationships
53--

Background*

Mr. Ian James Nicholson, B.Sc., MBA has been Chief Business Officer at NeRRe Therapeutics Ltd. since March 2014. Mr. Nicholson has been the Chief Executive Officer of F2G Ltd. since March 2013. Mr. Nicholson has been an Operating Partner at Advent Venture Partners since December 17, 2012. He is Operating Partner of London-based Advent Life Sciences LLP. He is employed as a part of the life sciences team. He served as the Chief Executive Officer of Chroma Therapeutics ...

Read Full Background

Corporate Headquarters*

Pitcairn House
Burton-on-Trent, Staffordshire DE14 2WW

United Kingdom

Phone: 44 12 8349 5010
Fax: 44 12 8349 5011

Board Members Memberships*

Director
Former Chief Executive Officer and Director
Non-Executive Chairman
2007-N/A
Former Director
2012-Present
Non-Executive Director, Chairman of Corporate Responsibility (CR) Committee, Member of Remuneration Committee, Member of Nomination Committee and Member of Audit Committee
2012-Present
Non-Executive Director, Chairman of Remuneration Committee, Member of Audit Committee and Member of Nomination Committee
2013-Present
Chief Executive Officer and Executive Director

Education*

MBA
Boston University
BS
University College London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLIN:LN 369.75 GBp +0.50

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLINIGEN GROUP PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.